JP2007537244A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007537244A5 JP2007537244A5 JP2007512735A JP2007512735A JP2007537244A5 JP 2007537244 A5 JP2007537244 A5 JP 2007537244A5 JP 2007512735 A JP2007512735 A JP 2007512735A JP 2007512735 A JP2007512735 A JP 2007512735A JP 2007537244 A5 JP2007537244 A5 JP 2007537244A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- branched
- linear
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000241A ITRM20040241A1 (it) | 2004-05-13 | 2004-05-13 | Camptotecine coniugate in posizione 20 con antagonisti delle integrine. |
| PCT/IT2005/000261 WO2005110487A2 (en) | 2004-05-13 | 2005-05-04 | Camptothecin derivatives conjugated in position 20 with integrin antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007537244A JP2007537244A (ja) | 2007-12-20 |
| JP2007537244A5 true JP2007537244A5 (https=) | 2008-06-26 |
Family
ID=35124307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007512735A Withdrawn JP2007537244A (ja) | 2004-05-13 | 2005-05-04 | ２０位にてインテグリンアンタゴニストと接合したカンプトテシン誘導体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20070232639A1 (https=) |
| EP (1) | EP1747019A2 (https=) |
| JP (1) | JP2007537244A (https=) |
| CN (1) | CN101010103A (https=) |
| AR (1) | AR049275A1 (https=) |
| AU (1) | AU2005243834A1 (https=) |
| BR (1) | BRPI0511037A (https=) |
| CA (1) | CA2562572A1 (https=) |
| IT (1) | ITRM20040241A1 (https=) |
| MX (1) | MXPA06012886A (https=) |
| TW (1) | TW200538125A (https=) |
| WO (1) | WO2005110487A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9216228B2 (en) | 2007-02-16 | 2015-12-22 | KTB Tumorforschungsgesellschaft MBM | Receptor and antigen targeted prodrug |
| WO2013110578A1 (en) * | 2012-01-27 | 2013-08-01 | F. Hoffmann-La Roche Ag | Integrin antagonist conjugates for targeted delivery to cells expressing alpha-v-beta-3 |
| CN105399757A (zh) * | 2015-12-29 | 2016-03-16 | 遵义医学院 | 酸敏感型喜树碱-20位去甲斑蝥酸酯衍生物及其抗肿瘤应用 |
| CN111068068A (zh) * | 2019-12-04 | 2020-04-28 | 云南民族大学 | 一种rgd多肽-喜树碱多肽药物偶联物及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19815812A1 (de) * | 1998-04-08 | 1999-10-14 | Bayer Ag | Modifizierte Cytostatika |
| EP1044977B1 (en) * | 1999-03-09 | 2002-05-02 | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | Camptothecin derivatives having antitumor activity |
| US6207832B1 (en) * | 1999-04-09 | 2001-03-27 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
| ATE438413T1 (de) * | 1999-09-08 | 2009-08-15 | Markus Albers | Integrin-vermittelte arzneimittel-zielrichtung |
-
2004
- 2004-05-13 IT IT000241A patent/ITRM20040241A1/it unknown
-
2005
- 2005-05-04 EP EP05743015A patent/EP1747019A2/en not_active Withdrawn
- 2005-05-04 AU AU2005243834A patent/AU2005243834A1/en not_active Abandoned
- 2005-05-04 US US11/596,189 patent/US20070232639A1/en not_active Abandoned
- 2005-05-04 CA CA002562572A patent/CA2562572A1/en not_active Abandoned
- 2005-05-04 TW TW094114403A patent/TW200538125A/zh unknown
- 2005-05-04 JP JP2007512735A patent/JP2007537244A/ja not_active Withdrawn
- 2005-05-04 MX MXPA06012886A patent/MXPA06012886A/es not_active Application Discontinuation
- 2005-05-04 CN CNA2005800152323A patent/CN101010103A/zh active Pending
- 2005-05-04 WO PCT/IT2005/000261 patent/WO2005110487A2/en not_active Ceased
- 2005-05-04 BR BRPI0511037-8A patent/BRPI0511037A/pt not_active IP Right Cessation
- 2005-05-12 AR ARP050101933A patent/AR049275A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010003868A (es) | Cis-imidazolinas quirales. | |
| EA200801998A1 (ru) | ПИРИДИН[3,4-b]ПИРАЗИНОНЫ | |
| JP2001247459A5 (https=) | ||
| DE60228857D1 (de) | Amino-phtalazinon derivate, anwendung als kinase inhibitoren, herstellung und pharmazeutische zusammensetzung | |
| CY1110332T1 (el) | Παραγωγα βενζιμιδαζολης, συνθεσεις που τα περιεχουν, παρασκευη αυτων και χρηση τους | |
| JP2014508804A5 (https=) | ||
| JP2002525329A5 (https=) | ||
| JP2001525394A5 (https=) | ||
| EE200000472A (et) | Kasvajavastased toimeained | |
| MX2009004898A (es) | Derivados de indol y de benzofurano-2-carboxamida. | |
| JP2008504235A5 (https=) | ||
| EP1379508A4 (en) | N- (ARYL) -2-ARYLETHESULFONAMIDES AND THEIR THERAPEUTIC APPLICATIONS | |
| EA200701780A1 (ru) | Противоопухолевое средство | |
| AU2002221622B2 (en) | Antitumor therapy comprising distamycin derivatives | |
| DE60231426D1 (de) | Solubilisierte topoisomerase-gift-mittel | |
| JP2002509858A5 (https=) | ||
| ATE390923T1 (de) | Topoisomerase-giftmittel | |
| JP2007537244A5 (https=) | ||
| JP2003516994A5 (https=) | ||
| CA2411172A1 (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase i and ii inhibitors | |
| CA2410160C (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents | |
| JP2007537243A5 (https=) | ||
| MA28930B1 (fr) | Derives pyridiniques d'indolin-2-one , leur preparation et leur application en therapeutique | |
| EP1482933A4 (en) | EFFECTIVE SIMPLIFIED DERIVATIVES OF IMMUNOSUPPRESSIVA | |
| JP2003535868A5 (https=) |